VRX Investor Alert: Kyros Law Files Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors

BOSTON, Jan. 30, 2018 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl VRX that it has filed legal claims on behalf of a group of shareholders against the company for possible securities fraud violations committed by Valeant Pharmaceuticals Intl VRX.

The complaint, filed in US District Court for the District of New Jersey, seeks to get compensation for a group of investors that have suffered millions of dollars of losses from investing in VRX stock.

Kyros Law is dedicated to fighting for the rights of these investors, and other investors that have lost money in VRX stock.

Valeant Pharmaceuticals Intl VRX investors that have invested over $100,000 before March 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to speak to someone about your case.

The complaint, filed by HUNG G. TA, ESQ. PLLC, SAFIRSTEIN METCALF LLP, and KYROS LAW, alleges violations of securities law committed by Valeant Pharmaceuticals Intl VRX management that has led to significant losses to investors. According to the complaint, Valeant Pharmaceuticals Intl VRX may have improperly used a pharmacy network to artificially increase sales for their drugs.

In February 2016, Valeant Pharmaceuticals Intl VRX announced it would restate its financial results, citing issues with revenue recognition stemming from sales from a specific pharmacy network. That same month, the company came under SEC investigation. During this time, the stock price of VRX dropped significantly, with the share prices dropping more than 90%.

Kyros Law Offices urges Valeant Pharmaceuticals Intl VRX  investors that invested more than $100,000 prior to March 2016 to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to find out if you have a case.

Kyros Law specializes in a wide range of complex litigation, mass torts, and corporate governance matters, including the representation of whistleblowers, shareholders and consumers in securities fraud, false claims act and class actions. Our lawyers have been responsible for recovering hundreds of millions of dollars for our clients throughout the United States, Africa, Asia and Europe. Visit our website to learn more about our firm.

View original content:http://www.prnewswire.com/news-releases/vrx-investor-alert-kyros-law-files-legal-claims-on-behalf-of-valeant-pharmaceuticals-intl-nyse-vrx-investors-300590151.html

SOURCE Kyros Law